Studies link these drugs to 20%-50% increased risk for developing chronic kidney disease (CKD) and 96% increased kidney failure risk. Consumers with kidney injuries are suing the manufacturers for failing to properly warn them about life-threatening side effect risks.
Time is limited! Fill out the form on this page to see if you qualify.
An advocate or attorney will contact you within minutes for your free consultation.
No fees unless you are awarded compensation!
Nexium (esomeprazole), Prevacid (lansoprazole), Prilosec (omeprazole) and Zegerid (omeprazole and sodium bicarbonate) are heartburn drugs known as proton pump inhibitors. Consumers take these reflux medications known as PPIs to treat severe gastroesophageal reflux disease (GERD) symptoms.
PPIs, the strongest heartburn drugs currently available, essentially halt gastric acid production in the stomach. PPIs are available in prescription and over-the-counter (OTC) formulations.
Consumers began filing PPI-induced injury claims and false advertising lawsuits in 2004. AstraZeneca, which manufactures Nexium and Prilosec, settled one class action lawsuit in 2013 for $20 million. And in 2015, the company settled kickback scheme allegations from the U.S. Justice Department out of court for $7.9 million. Thousands of individual kidney injury claims are still pending against Zegerid’s manufacturer, Bayer, and Pfizer, the company that makes Prevacid.
